MEDELLA THERAPEUTICS LTD.
Medella Therapeutics, a spinout company from the University of Sheffield, is developing new cancer treatments using monoclonal antibodies – proteins made by the immune system that bind to a single target, such as a cancer cell – that have fewer side effects than many other therapies.
MEDELLA THERAPEUTICS LTD.
Industry:
Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Sheffield, Sheffield, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
320 K GBP
Similar Organizations
Oregon Therapeutics
Oregon Therapeutics is a developer of new anti-cancer drugs.
Investors List
Fusion IP
Fusion IP investment in Seed Round - Medella Therapeutics Ltd.